0001145549-24-048183.txt : 20240813 0001145549-24-048183.hdr.sgml : 20240813 20240813110706 ACCESSION NUMBER: 0001145549-24-048183 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240531 FILED AS OF DATE: 20240813 DATE AS OF CHANGE: 20240813 EFFECTIVENESS DATE: 20240813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tidal ETF Trust CENTRAL INDEX KEY: 0001742912 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-23377 FILM NUMBER: 241199531 BUSINESS ADDRESS: STREET 1: 234 WEST FLORIDA STREET, SUITE 203 CITY: MILWAUKEE, STATE: WI ZIP: 53204 BUSINESS PHONE: 844-986-7676 MAIL ADDRESS: STREET 1: 234 WEST FLORIDA STREET, SUITE 203 CITY: MILWAUKEE, STATE: WI ZIP: 53204 0001742912 S000075593 Newday Ocean Health ETF C000234814 Newday Ocean Health ETF AHOY N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001742912 XXXXXXXX false false false N-1A S000075593 true Tidal ETF Trust 811-23377 0001742912 549300VTYHP8U2332C46 c/o Tidal ETF Services, LLC 234 West Florida Street, Suite 203 Milwaukee 53204 US-WI US 8449867700 U.S. Bancorp Fund Services LLC 615 East Michigan St. Milwaukee 53202 18336121912 Maintain physical/electronic accounts/books or any document required by section 31(a) of the Act (15 U.S.C. 80a-30(a)) and the rules under that section. N N N N-1A 33 Y Dusko Culafic N/A N Eduardo Mendoza N/A N Mark H.W. Baltimore N/A N Eric W. Falkeis N/A Y William H. Woolverton N/A c/o Tidal ETF Services, LLC 234 West Florida, Suite 203 Milwaukee 53204 XXXXXX N N N N N Foreside Fund Services, LLC 8-51293 000046106 N/A N N Tait Weller and Baker LLP 00445 N/A Cohen & Company, Ltd. 00925 N/A N N N 2024-02-21 Valuation Designee evaluation determined mean of bid/ask more appropriate Derivative-other Options contracts N/A N N Newday Ocean Health ETF S000075593 54930001DS2RDVNL1X98 N 1 0 0 Exchange-Traded Fund Y N N N N/A N/A N/A Rule 6c-11 (17 CFR 270.6c-11) N N N N Tidal Investments LLC 801-76857 000164201 N/A N Newday Funds, Inc. 801-112212 000174758 N/A N N U.S. Bancorp Fund Services LLC 85-11357 N1GZ7BBF3NP8GI976H15 N N N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Bloomberg L.P. 549300B56MD0ZC402L06 N LSEG Data & Analytics N/A GB N IHS Markit Ltd. 549300HLPTRASHS0E726 BM N Standard and Poors Financial Services LLC 549300U4VWNITEKO2881 N N U.S. Bank N.A. 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N Tidal ETF Services, LLC N/A Y N U.S. Bancorp Global Fund Services LLC N1GZ7BBF3NP8GI976H15 N Y N GOLDMAN SACHS & CO. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 1.110000000000 MERRILL LYNCH PIERCE FENNER & SMITH INCORPORATED 8-7221 000007691 8NAV47T0Y26Q87Y0QP81 1031.150000000000 1032.260000000000 0.000000000000 N 2532468.360000000000 N N N N Newday Ocean Health ETF S000075593 N 25000.000000000000 0.700000000000 0.210000000000 99.300000000000 0.210000000000 0.930000000000 0.000000000000 99.070000000000 0.000000000000 0.000000000000 300.000000000000 0.000000000000 0.000000000000 300.000000000000 0.000000000000 0.000000000000 300.000000000000 0.000000000000 0.000000000000 300.000000000000 0.000000000000 Y true INTERNAL CONTROL RPT 2 newday.htm AHOY ETF - 05.31.24 INTERNAL CONTROL LETTER

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders of Newday Ocean Health ETF and
Board of Trustees of Tidal ETF Trust

In planning and performing our audit of the financial statements of Newday Ocean Health (the “Fund”), a series of Tidal ETF Trust, as of and for the year ended May 31, 2024, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting.  Accordingly, we express no such opinion.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP).  A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB.  However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of May 31, 2024.

This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ COHEN & COMPANY, LTD.

COHEN & COMPANY, LTD.
Milwaukee, Wisconsin
July 30, 2024